✦ LIBER ✦

Tues-P22 - The cost-effectiveness of Ixel®, A new SNRI, in comparison with a panel of TCAs and SSRIs, in the treatment of depression

✍ Scribed by G. Berdeaux; R. Dardennes; A. Lafuma; F. Fagnani

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of the cost-effectiveness of

✍ R Dardennes; G Berdeaux; A Lafuma; F Fagnani 📂 Article 📅 1999 🏛 Elsevier Science 🌐 French ⚖ 194 KB

P.2.a.020 The effects of escitalopram on

✍ D. Stein; A. Garcia Lopez 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Glucosamine sulphate in the treatment of

✍ S. Scholtissen; O. Bruyère; A. Neuprez; J. L. Severens; G. Herrero-Beaumont; L. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 254 KB

PMH3 A COST-EFFECTIVENESS COMPARISON OF

✍ S Beard; M Lothgren; L Giudi; F Ramacciotti; M Nardini; D Berardi 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

The cost-effectiveness of a smoking cess

✍ Paul G. Barnett; Wynnie Wong; Sharon Hall 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

EPA-0264 – A Cost-utilty analysis of ven

✍ Graham, C.; Narula, H.; Liu, L.Z.; Keohane, D.; Di Virgilio, R. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 French ⚖ 64 KB